Master of Bioscience Enterprise
Study Programme Details
About this Study Course
The Master of Bioscience Enterprise (MBioEnt) is a cutting-edge interdisciplinary research master’s degree, seamlessly blending the realms of Science, Business, and Law. Tailored for Science graduates, this program instills the skills and confidence needed to navigate the dynamic business landscape with a scientific perspective.
Overview
Delivered collaboratively by the School of Biological Sciences, the Business School, and the Faculty of Law, the MBioEnt is designed to empower scientists in understanding and safeguarding the value of their research. This program goes beyond traditional boundaries, equipping you with the ability to translate groundbreaking discoveries into high-value products. Through a comprehensive curriculum, you’ll delve into strategies for commercialization, gain insights into intellectual property law, utilize valuation tools, and master the art of crafting a business plan.
Admission Requirements
- You must have completed the Postgraduate Diploma in Bioscience Enterprise (PGDipBioEnt) at the University of Auckland with a GPA of 6.0 in at least 90 points.
- IELTS 6.5 and the writing test score 6.0
- C2 Proficiency – Cambridge English Qualifications with pass grade A, B or C.
- C1 Advanced – Cambridge English Qualifications with pass grade A, B or C.
- TOEFL iBT 90 and the writing test score 20
- 90-point thesis completed as a research project and submitted during a six-month industry internship
- 30 points from courses on the following topics: Science Enterprise Research Methods; Product
- Domestic studentsNZ$9,451.20*
- International studentsNZ$50,810
Future Career Outcomes
As an MBioEnt graduate, you emerge equipped to shape the future of bioscience enterprise. Your journey could lead to impactful roles as a Biotech Entrepreneur, Intellectual Property Analyst, or Technology Transfer Specialist. Beyond these, you’ll be well-positioned for diverse careers at the intersection of science, business, and law, driving innovation and contributing to the growth of the bioscience sector.